A Taxpayer-Funded Clinical Trials Registry and Results Database
PLoS MedicinePublished 18 November 2004Open access
Erick H. Turner
Citations55
SJR quartileQ1
SJR score4.28
SNIP3.21
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
It already exists within the US Food and Drug Administration, argues a former clinical reviewer of psychotropic drugs at the FDA
Keywords
Decision SciencesMedicineEconomics, Econometrics and Finance
JAMAEmpirical Evidence for Selective Reporting of Outcomes in Randomized Trials
1,806 Citations2004An‐Wen Chan, Asbjørn Hróbjartsson +3 more
The reporting of trial outcomes is not only frequently incomplete but also biased and inconsistent with protocols and Published articles, as well as reviews that incorporate them, may therefore be unreliable and overestimate the benefits of an intervention.
JAMARegistering Clinical Trials
514 Citations2003Kay Dickersin
All stakeholders-investigators, research organizations and institutions, journal editors, lawmakers, consumers, and others-must act now, together and in their own domains, to ensure comprehensive registration of clinical trials.
PubMedHow important is publication bias? A synthesis of available data.
312 Citations1997Kay Dickersin
This article will review the major evidence available regarding publication bias and will suggest measures for overcoming the problem.
The Journal of Clinical PsychiatryParoxetine in the Treatment of Generalized Anxiety Disorder
248 Citations2001Mark H. Pollack, Rocco Zaninelli +5 more
Paroxetine in doses of 20 to 50 mg once daily is effective in the treatment of patients with GAD and is associated with significant reduction in disability after only 8 weeks of treatment.
Cochrane Database of Systematic ReviewsAntidepressants for generalised anxiety disorder (GAD)
162 Citations2003Flávio Kapczinski, Juliano JSS dos Santos Souza +2 more
Antidepressants (imipramine, venlafaxine and paroxetine) were found to be superior to placebo in treating GAD.
BMJCompulsory registration of clinical trials
79 Citations2004Kamran Abbasi
Will be a requirement before submission to the BMJ from July 2005 and will be reviewed every two years after this date.
CNS DrugsParoxetine Controlled Release
26 Citations2004Lynne M Bang, Gillian M. Keating
In well designed placebo-controlled trials in patients with major depressive disorder, social anxiety disorder or premenstrual dysphoric disorder, paroxetine CR was consistently superior to placebo with regards to primary endpoints.